Table 1.

Correlation analysis of PRPF19 with pathological parameters of bladder cancer.

Characteristics	High	Low	P value
n	36	20
Age, n (%)			0.147
≥65	22 (39.3%)	16 (28.6%)
<65	14 (25%)	4 (7.1%)
Gender, n (%)			0.588
male	29 (51.8%)	18 (32.1%)
female	7 (12.5%)	2 (3.6%)
Tumor size, n (%)			0.359
≥4	17 (30.4%)	12 (21.4%)
<4	19 (33.9%)	8 (14.3%)
Grade, n (%)			0.209
High	31 (55.4%)	20 (35.7%)
Low	5 (8.9%)	0 (0%)
pT-Stage T, n (%)			0.686
≥T2	27 (48.2%)	14 (25%)
<T2	9 (16.1%)	6 (10.7%)
pTNM-Stage, n (%)			0.038
>II	23 (41.1%)	7 (12.5%)
≤II	13 (23.2%)	13 (23.2%)
External aggression, n (%)			0.209
yes	5 (8.9%)	0 (0%)
No	31 (55.4%)	20 (35.7%)
Lymph node metastasis, n (%)			0.588
yes	7 (12.5%)	2 (3.6%)
No	29 (51.8%)	18 (32.1%)
Status, n (%)			0.013
Dead	25 (44.6%)	7 (12.5%)
Alive	11 (19.6%)	13 (23.2%)